Article Details

Phio Pharmaceuticals (NASDAQ:PHIO) Upgraded to “Hold” at Zacks Investment Research

Retrieved on: 2022-06-08 15:12:36

Tags for this article:

Click the tags to see associated articles and topics

Phio Pharmaceuticals (NASDAQ:PHIO) Upgraded to “Hold” at Zacks Investment Research. View article details on hiswai:

Excerpt

Millennium Management LLC now owns 122,693 shares of the company's stock valued at $248,000 after acquiring an additional 112,658 shares during the ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up